Serum ghrelin, IL-6 and TNF-? levels in patients with chronic obstructive pulmonary disease

dc.contributor.authorDeveci, Yasemin
dc.contributor.authorDeveci, Figen
dc.contributor.authorIlhan, Nevin
dc.contributor.authorKaraca, Ilgin
dc.contributor.authorTurgut, Teyfik
dc.contributor.authorMuz, Mehmet Hamdi
dc.date.accessioned2026-08-12T17:03:31Z
dc.date.issued2010
dc.departmentFırat Üniversitesi
dc.description.abstractIt is determined that endocrine factors can play role on cachexia in chronic obstructive pulmonary disease (COPD). High levels of ghrelin is reported in cachectic COPD cases but its' relation couldn't shown statistically. In our study, it is aimed to detect serum ghrelin levels in COPD, its' relation with proinflammatory cytokines and whether serum ghrelin is associated with cachexia. Sixty stable COPD patients and 15 healthy volunteers were included in the study. COPD patients were divided into two groups, cachectic and normal weight, according to their body mass index. Spirometric assessments were performed and serum tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) and ghrelin levels were measured in all cases. When COPD patients were compared with control group; serum ghrelin levels were statistically lower, TNF-alpha and IL-6 levels were statistically higher in COPD group. For cachectic COPD patients; serum ghrelin levels were statistically lower and IL-6 levels were statistically higher, compared with normal weight COPD patients. Although, serum TNF-alpha levels were higher for cachectic COPD patients; these levels were not significant. Positive correlation between serum ghrelin levels and body mass index was detected in patients with COPD. As a result; it is thought that increased proinflammatory cytokins and decreased serum active ghrelin levels may contribute to the development of weight loss.
dc.identifier.endpage172
dc.identifier.issn0494-1373
dc.identifier.issue2
dc.identifier.orcid0000-0003-1656-2481
dc.identifier.orcid0000-0002-0208-8929
dc.identifier.pmid20865569
dc.identifier.scopus2-s2.0-77955297354
dc.identifier.scopusqualityQ3
dc.identifier.startpage162
dc.identifier.urihttps://hdl.handle.net/11508/48344
dc.identifier.volume58
dc.identifier.wosWOS:000421274100007
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isotr
dc.publisherTurkish Assoc Tuberculosis & Thorax
dc.relation.ispartofTuberkuloz ve Torak-Tuberculosis and Thorax
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectCOPD
dc.subjectghrelin
dc.subjectTNF-alpha
dc.subjectIL-6
dc.titleSerum ghrelin, IL-6 and TNF-? levels in patients with chronic obstructive pulmonary disease
dc.title.alternativeKronik obstrüktif akci?er hastali?i olan olgularda serum grelin, IL-6 ve TNF-? düzeyleri
dc.typeArticle

Dosyalar